These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 24765227)

  • 1. Updated Physician's Guide to the Off-label Uses of Oral Isotretinoin.
    Nickle SB; Peterson N; Peterson M
    J Clin Aesthet Dermatol; 2014 Apr; 7(4):22-34. PubMed ID: 24765227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral isotretinoin for the treatment of dermatologic conditions other than acne: a systematic review and discussion of future directions.
    Chu S; Michelle L; Ekelem C; Sung CT; Rojek N; Mesinkovska NA
    Arch Dermatol Res; 2021 Aug; 313(6):391-430. PubMed ID: 33151346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-acne dermatologic indications for systemic isotretinoin.
    Akyol M; Ozçelik S
    Am J Clin Dermatol; 2005; 6(3):175-84. PubMed ID: 15943494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders.
    Ward A; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 Jul; 28(1):6-37. PubMed ID: 6235105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermatological indications for the use of isotretinoin beyond acne.
    Forbat E; Ali FR; Al-Niaimi F
    J Dermatolog Treat; 2018 Nov; 29(7):698-705. PubMed ID: 29480033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Isotretinoin and Its Uses in Dermatology: A Review.
    Paichitrojjana A; Paichitrojjana A
    Drug Des Devel Ther; 2023; 17():2573-2591. PubMed ID: 37649956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral isotretinoin for acne.
    Costa CS; Bagatin E; Martimbianco ALC; da Silva EM; Lúcio MM; Magin P; Riera R
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD009435. PubMed ID: 30484286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Off-label dermatologic uses of IL-17 inhibitors.
    Wu KK; Dao H
    J Dermatolog Treat; 2022 Feb; 33(1):41-47. PubMed ID: 32116066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 13-cis retinoic acid in lamellar ichthyosis, pityriasis rubra pilaris and Darier's disease.
    Gilgor RS; Chiaramonti A; Goldsmith LA; Lazarus GS
    Cutis; 1980 Apr; 25(4):380-1, 385. PubMed ID: 6928816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Off-label uses of ustekinumab.
    Ye L; Wu Z; Li C; Zhao X; Wan M; Wang L
    Dermatol Ther; 2022 Dec; 35(12):e15910. PubMed ID: 36208443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral isotretinoin treatment policy. Do we all agree?
    Ortonne JP
    Dermatology; 1997; 195 Suppl 1():34-7; discussion 38-40. PubMed ID: 9310744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotretinoin-associated acne fulminans: A multicentre, retrospective study of the European Academy of Dermatology and Venereology Task Force on Acne, Rosacea and Hidradenitis Suppurativa.
    Dessinioti C; Dréno B; Bettoli V; Vural S; Brzezinski P; Nassif A; Svensson Å; Zouboulis CC
    J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):197-204. PubMed ID: 37643921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isotretinoin--unapproved indications/uses and dosage: a physician's reference.
    Sehgal VN; Srivastava G; Sardana K
    Int J Dermatol; 2006 Jun; 45(6):772-7. PubMed ID: 16796650
    [No Abstract]   [Full Text] [Related]  

  • 14. Dermoscopy in General Dermatology: A Practical Overview.
    Errichetti E; Stinco G
    Dermatol Ther (Heidelb); 2016 Dec; 6(4):471-507. PubMed ID: 27613297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative uses of ustekinumab for non-indicated dermatological conditions: a systematic review.
    Rawal S; Kianian S; Guo W; Marquez J; Ayasse M; Siamas KA; Lee Y; Salvemini J
    Arch Dermatol Res; 2022 Aug; 314(6):503-514. PubMed ID: 34156549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The versatility of azelaic acid in dermatology.
    Searle T; Ali FR; Al-Niaimi F
    J Dermatolog Treat; 2022 Mar; 33(2):722-732. PubMed ID: 32730109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secukinumab for the treatment of adult-onset pityriasis rubra pilaris: a single-arm clinical trial with transcriptomic analysis.
    Boudreaux BW; Pincelli TP; Bhullar PK; Patel MH; Brumfiel CM; Li X; Heckman MG; Pittelkow MR; Mangold AR; Sluzevich JC
    Br J Dermatol; 2022 Nov; 187(5):650-658. PubMed ID: 35701384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isotretinoin-induced sacroiliitis in patients with hidradenitis suppurativa: a case-based review.
    Coskun BN; Yagiz B; Pehlivan Y; Dalkilic E
    Rheumatol Int; 2019 Dec; 39(12):2159-2165. PubMed ID: 31455984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Darier's disease, lamellar ichthyosis, pityriasis rubra pilaris, cystic acne, and basal cell carcinoma with oral 13-cis-retinoic acid.
    Peck GL; Yoder FW; Olsen TG; Pandya MD; Butkus D
    Dermatologica; 1978; 157 Suppl 1():11-2. PubMed ID: 150981
    [No Abstract]   [Full Text] [Related]  

  • 20. Off-label use of fumarate therapy for granulomatous and inflammatory skin diseases other than psoriasis vulgaris: a retrospective study.
    Klein A; Coras B; Landthaler M; Babilas P
    J Eur Acad Dermatol Venereol; 2012 Nov; 26(11):1400-6. PubMed ID: 22007931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.